Atkinson R L
Fed Proc. 1987 Jan;46(1):178-82.
Relatively few studies of humans have evaluated the effects of opioids on food intake and body weight. Most have focused on the potential role of opioids in the etiology of obesity. Measurements of endogenous opioids in plasma or spinal fluid of humans reveal higher levels, particularly of beta-endorphin, in obese subjects. Opioid agonists such as methadone and butorphanol tartrate stimulate food intake, and all studies with naloxone, an opioid antagonist, demonstrate a reduction of short-term food intake in obese or lean humans. Long-term studies with naltrexone, an antagonist similar to naloxone, show no effect on food intake or body weight. Opioid agonists or antagonists have little effect on nutrient selection in humans. The effects on feeding-related hormones is equivocal. Further studies with more specific opioid receptor activities are needed.
相对较少的人体研究评估了阿片类药物对食物摄入量和体重的影响。大多数研究集中在阿片类药物在肥胖病因学中的潜在作用。对人体血浆或脑脊液中内源性阿片类物质的测量显示,肥胖受试者体内的水平较高,尤其是β-内啡肽。美沙酮和酒石酸布托啡诺等阿片类激动剂会刺激食物摄入,而所有使用阿片类拮抗剂纳洛酮的研究都表明,肥胖或瘦的人短期食物摄入量会减少。使用与纳洛酮类似的拮抗剂纳曲酮进行的长期研究表明,对食物摄入量或体重没有影响。阿片类激动剂或拮抗剂对人类的营养选择影响很小。对与进食相关激素的影响尚不清楚。需要进行更多关于更特异性阿片受体活性的研究。